Medtech 2026: Is Investor Confidence Back?

 
• By Marion Webb and Elizabeth Orr
  
perspectives 2026
Investors are back for medtech -- but companies backed by strong clinical evidence are the most likely to attract capital. (Pixel-shot/Shutterstock)

More from Medtech Insight Perspectives

More from Medtech Insight